Verona Pharma plc (VRNA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:34 pm
Purchase
2020-12-3113GVerona Pharma plc
VRNA
RA Capital Management, L.P.41,543,004
9.990%
41,543,004increase
(New Position)
Filing
History
2021-02-05
4:38 pm
Sale
2021-02-0213GVerona Pharma plc
VRNA
Novo Holdings A/S12,893,250
3.100%
-9,746,417decrease
(-43.05%)
Filing
History
Goto Prev, 0, 1, 2